Plasma pTau181 has a high specificity for AD (compared to CSF Tau) and sensitivity [42,43,44,45], suggesting that it might possess potential in the differential diagnostics between AD and other types of dementia, especially compared to traditional CSF-based Tau measurements. This evidence concerns the gene MAPT and Alzheimer disease.